EDS has been identified as a rare autosomal dominant connective tissue disorder resulting from mutations in the COL3A1 gene encoding for type III collagen synthesis.1) In 2017, a new classification of EDS was established. The gene discussed is COL3A1; the disease is Ehlers-Danlos syndrome.